Filamentous hemagglutinin ofBordetella pertussis: a key adhesin with immunomodulatory properties?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Filamentous hemagglutinin ofBordetella pertussis: a key adhesin with immunomodulatory properties?
Authors
Keywords
-
Journal
Future Microbiology
Volume 9, Issue 12, Pages 1339-1360
Publisher
Future Medicine Ltd
Online
2014-12-17
DOI
10.2217/fmb.14.77
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bordetella pertussis pathogenesis: current and future challenges
- (2014) Jeffrey A. Melvin et al. NATURE REVIEWS MICROBIOLOGY
- Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort
- (2013) Maxwell A. Witt et al. CLINICAL INFECTIOUS DISEASES
- The Bordetella pertussis Type III Secretion System Tip Complex Protein Bsp22 Is Not a Protective Antigen and Fails To Elicit Serum Antibody Responses during Infection of Humans and Mice
- (2013) Rodrigo Villarino Romero et al. INFECTION AND IMMUNITY
- In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
- (2013) Nicolas Hegerle et al. MICROBES AND INFECTION
- Waning Immunity to Pertussis Following 5 Doses of DTaP
- (2013) S. Y. Tartof et al. PEDIATRICS
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pertussis: Challenges Today and for the Future
- (2013) James D. Cherry PLoS Pathogens
- Bordetella pertussisentry into respiratory epithelial cells and intracellular survival
- (2013) Yanina Lamberti et al. Pathogens and Disease
- Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak
- (2012) Maxwell A. Witt et al. CLINICAL INFECTIOUS DISEASES
- Nonhuman Primate Model of Pertussis
- (2012) Jason M. Warfel et al. INFECTION AND IMMUNITY
- Contribution of Bordetella Filamentous Hemagglutinin and Adenylate Cyclase Toxin to Suppression and Evasion of Interleukin-17-Mediated Inflammation
- (2012) Michael W. Henderson et al. INFECTION AND IMMUNITY
- Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010
- (2012) Lara K. Misegades et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Newly Emerging Clones of Bordetella pertussis Carrying prn2 and ptxP3 Alleles Implicated in Australian Pertussis Epidemic in 2008–2010
- (2012) Sophie Octavia et al. JOURNAL OF INFECTIOUS DISEASES
- California Pertussis Epidemic, 2010
- (2012) Kathleen Winter et al. JOURNAL OF PEDIATRICS
- The prodomain of theBordetellatwo-partner secretion pathway protein FhaB remains intracellular yet affects the conformation of the mature C-terminal domain
- (2012) Christopher R. Noël et al. MOLECULAR MICROBIOLOGY
- Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates
- (2012) J M Warfel et al. Mucosal Immunology
- Immunity to the respiratory pathogen Bordetella pertussis
- (2012) R Higgs et al. Mucosal Immunology
- Why Do Pertussis Vaccines Fail?
- (2012) J. D. Cherry PEDIATRICS
- The ins and outs of pertussis toxin
- (2011) Camille Locht et al. FEBS Journal
- Laboratory Adaptation of Bordetella pertussis Is Associated with the Loss of Type Three Secretion System Functionality
- (2011) M. E. Gaillard et al. INFECTION AND IMMUNITY
- Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis
- (2011) Hyun-Ja Han et al. PLoS One
- Bordetella pertussis Autotransporter Vag8 Binds Human C1 Esterase Inhibitor and Confers Serum Resistance
- (2011) Nico Marr et al. PLoS One
- Modulation of the Host Interferon Response and ISGylation Pathway by B. pertussis Filamentous Hemagglutinin
- (2011) Christine Dieterich et al. PLoS One
- The Present and Future Control of Pertussis
- (2010) James D. Cherry CLINICAL INFECTIOUS DISEASES
- Pertussis toxin and adenylate cyclase toxin: key virulence factors ofBordetella pertussisand cell biology tools
- (2010) Nicholas H Carbonetti Future Microbiology
- Intracellular Trafficking of Bordetella pertussis in Human Macrophages
- (2010) Y. A. Lamberti et al. INFECTION AND IMMUNITY
- Monocyte-Derived Interleukin-10 Depresses the Bordetella pertussis- Specific Gamma Interferon Response in Vaccinated Infants
- (2009) V. Dirix et al. Clinical and Vaccine Immunology
- Virulence factor secretion and translocation by Bordetella species
- (2009) Ruchi Shrivastava et al. CURRENT OPINION IN MICROBIOLOGY
- Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins ofBordetella pertussisandBordetella bronchisepticaand reveal a role for the mature C-terminal domain, but not the RGD motif, during infection
- (2009) Steven M. Julio et al. MOLECULAR MICROBIOLOGY
- Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune Responses
- (2008) N. K. Fennelly et al. INFECTION AND IMMUNITY
- Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils
- (2008) Yanina Lamberti et al. MICROBIAL PATHOGENESIS
- Modulation of the NF-κB Pathway by Bordetella pertussis Filamentous Hemagglutinin
- (2008) Tzvia Abramson et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started